MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Georges Gemayel
Georges GemayelGEMINI THERAPEUTICS

Georges Gemayel

Chairman and interim CEO at GEMINI THERAPEUTICS

Manager

Deal Bio

Total Deals2
Valued Deals1
Total Value£ 15 M
Avg. Deal Size£ 15 M

Market Context

Sort

31 May 2022|Denmark|Biotechnology
Orphazyme
KEMPHARM

Target: ORPHAZYME A/S

Bidder: KEMPHARM

2 Service Providers

2 Target

10 Dealmakers

10 Target

£ 14 M

Value

10 Aug 2022|United States|Pharmaceuticals
Gemini Therapeutics
Disc Medicine

Target: GEMINI THERAPEUTICS

Bidder: DISC MEDICINE

10 Service Providers

5 Target | 5 Bidder

20 Dealmakers

17 Target | 3 Bidder

n/a

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite